Shareholders' Equity

3 Months Ended

Mar. 31, 2013

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders’ Equity

The following table presents a summary of ordinary shares issued and related cash proceeds and payments (in thousands):

	Three Months Ended March 31, 2013				Three Months Ended March 31, 2012
	Shares	Cash			Shares	Cash
Azur Merger	—	$	—		12,360	$	—
Employee withholding taxes related to share-based awards (1)	—	(1,427		)	—	(25,299		)
Exercises of share options and warrants and vested RSUs	826	9,609			1,722	5,160
Directors’ deferred compensation plan	—	—			29	—
Totals	826	$	8,182		14,111	$	(20,139	)

 ____________________

(1) During the three months ended March 31, 2013, we paid $1.4 million of income tax withholdings on behalf of employees related to the net share settlement of vested RSUs. During the three months ended March 31, 2012, we paid $25.3 million of income tax withholdings on behalf of certain employees of Jazz Pharmaceuticals, Inc. related to the net share settlement of exercised share options in connection with the Azur Merger. The income tax withholdings paid were recorded as a reduction to additional paid-in capital.

Accumulated Other Comprehensive Income

The components of accumulated other comprehensive income as of March 31, 2013 and December 31, 2012 were as follows (in thousands):

	Foreign Currency Translation Adjustments			Total Accumulated Other Comprehensive Income
Balance at December 31, 2012	$	31,046		$	31,046
Other comprehensive loss	(20,440		)	(20,440		)
Balance at March 31, 2013	$	10,606		$	10,606

During the three months ended March 31, 2013, other comprehensive loss reflects foreign currency translation adjustments which are primarily due to the strengthening of the U.S. dollar against the Euro.